Rituximab addition to chemotherapy in real world patients with chronic lymphocytic leukemia: effective in first line but indication of lack of efficacy in subsequent lines of therapy.

van der Straten, Lina; Dinmohamed, Avinash G; Westerweel, Peter E; Langerak, Anton W; Riedl, Jurgen; Doorduijn, Jeanette K; Kater, Arnon P; Levin, Mark-David

van der Straten, Lina; Dinmohamed, Avinash G; Westerweel, Peter E; Langerak, Anton W; Riedl, Jurgen; Doorduijn, Jeanette K; Kater, Arnon P; Levin, Mark-David.

Affiliation

van der Straten L; a Department of Internal Medicine , Albert Schweitzer Hospital , Dordrecht , The Netherlands.
Dinmohamed AG; b Department of Research , Netherlands Comprehensive Cancer Organisation (IKNL) , Utrecht , The Netherlands.
Westerweel PE; c Department of Public Health , Erasmus University Medical Centre , Rotterdam , The Netherlands.
Langerak AW; d Department of Hematology , Erasmus MC Cancer Institute , Rotterdam , The Netherlands.
Riedl J; a Department of Internal Medicine , Albert Schweitzer Hospital , Dordrecht , The Netherlands.
Doorduijn JK; e Department of Immunology , Erasmus University Medical Centre , Rotterdam , The Netherlands.
Kater AP; f Department of Clinical Chemistry , Result laboratories, Albert Schweitzer Hospital , Dordrecht , The Netherland.
Levin MD; d Department of Hematology , Erasmus MC Cancer Institute , Rotterdam , The Netherlands.

Leuk Lymphoma ; 59(11): 2757-2761, 2018 11.

Article in En | MEDLINE | ID: mdl-29616852

Subject(s)

Leukemia, Lymphocytic, Chronic, B-Cell; Antibodies, Monoclonal, Murine-Derived; British Columbia; Cyclophosphamide; Humans; Rituximab

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell Limits: Humans Country/Region as subject: America do norte Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2018 Type: Article Affiliation country: Netherlands

Fulltext

XML

PubMed Links

Search on Google